Eczema is a group of inflammatory and chronic skin conditions, and it is the most common skin disease among older people. As many as one in two people aged over 60 suffer from some form of eczema. A ...
It’s helping other people as well as helping you.” That’s the message from Andrew Goodison, a 47-year-old from Sheffield, who ...
Minimally important difference in diffuse systemic sclerosis: results from the d-penicillamine study
1 Division of Immunology, Department of Medicine; Institute for the Study of Health, University of Cincinnati, Cincinnati, Ohio, USA; Veterans Affairs Medical Center, Cincinnati 2 Department of ...
Zacks Investment Research on MSN
Novartis' ianalumab wins breakthrough therapy tag for Sjogren's disease
Novartis NVS announced that the FDA granted Breakthrough Therapy designation to its pipeline candidate, ianalumab for the treatment of adult patients with Sjogren’s disease — a chronic, systemic ...
Comorbidity. Just seeing that word makes me cringe. It means having two or more coexisting, and often chronic, health conditions. For many of us in the rare disease community, comorbidity means ...
Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2025" report has been added to ResearchAndMarkets.com's offering. The clinical trial ...
Background Systemic sclerosis, also known as scleroderma, is a complex, multi-organ disease which causes substantial and progressive fibrosis of the skin and internal organs, including the heart and ...
Scleroderma is a rare autoimmune disease involving an overproduction of the protein collagen. Linear scleroderma usually begins as a streak of hardened, waxy, discolored skin on the forehead, an arm, ...
Objectives (1) To assess the risk of haematological malignancies in individuals with systemic sclerosis (SSc) compared with individuals without SSc; (2) to explore how the risk varies across groups ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results